Annexon CEO Touts “Win Year” 2026 at Needham, Eyes GA Phase III Data and GBS FDA Filing

President and CEO Doug Love outlined a series of anticipated clinical and regulatory milestones during the 25th Annual ...

argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...

30 Large Garden Ideas to Unlock the Full Potential of Your Land

Discover large garden ideas to give your outdoor space more beauty and functionality. Think: pathways, trellises, raised beds ...

Audition on April 25 for Algoma University’s Great Lakes International Summer Music Experience Program

Algoma University’s Great Lakes International Summer Music Experience is turning its Sault Ste. Marie campus into a two-week ...
AHA/ASA Journals

Targeting Interleukin-8–Mediated Cellular Crosstalk Reverses Hypertrophic Cardiomyopathy and Cardiac Fibrosis in Noonan Syndrome

BACKGROUND: Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome ...
Scientific Research Publishing

Analytical Chemistry of New Psychoactive Substances: Methods, Applications and Future Prospects ()

New psychoactive substances (NPS) are a class of artificially designed and synthesized chemical substances designed to mimic the pharmacological effects of traditional drugs. They are characterized by ...